Dr. Reddy's Tizanidine Tablets Recall: Foreign Glimepiride Tablets Found
Dr. Reddy's recalls 2mg Tizanidine HCl tablets due to glimepiride tablets found in some bottles. This could cause unintended medication effects. Contact for return instructions.
Lower-risk recall
Presence of Foreign Tablets/Capsules: Glimepiride tablet was found in a bottle of Tinzadine Hcl Tablets .
Contact the company
What happened, in plain English
Dr. Reddy's is recalling 2mg Tizanidine HCl tablets that contain foreign glimepiride tablets. This could lead to unintended medication effects if taken. Affected products were manufactured in India with specific lot numbers. Read more at govinfonow.com/recall/39659-dr-reddy-s-tizanidine-tablets-recall-foreign-glimepiride-tablets-found.
Source Summary by GovInfoNow · govinfonow.com/recall/39659-dr-reddy-s-tizanidine-tablets-recall-foreign-glimepiride-tablets-found · Updated October 6, 2026 · FDA enforcement record: FDA #D-1191-2018
Cite this page
“Dr. Reddy's Tizanidine Tablets Recall: Foreign Glimepiride Tablets Found.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39659-dr-reddy-s-tizanidine-tablets-recall-foreign-glimepiride-tablets-found. Based on FDA recall #D-1191-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1191-2018%22&limit=1).
Why it’s dangerous
The recall involves finding glimepiride tablets inside bottles of Tizanidine HCl tablets. Glimepiride is a different medication that could cause unintended effects if taken with Tizanidine. This is a contamination issue that may lead to incorrect medication intake.
Who’s affected
People who have prescription Tizanidine HCl tablets from Dr. Reddy's in India with lot number T800304. Those taking the medication are most at risk if they accidentally consume the foreign tablets.
How to tell if you have this one
Check for the lot number T800304 on the bottle. The product was manufactured in India with NDC 55111-179-15 and UPC 35511179153. The tablets are prescription-only 2mg Tizanidine HCl tablets in 150-count bottles.
- Brand
Dr. Reddy's- Product
Tizanidine HCl Tablets, USP 2mg, 150-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited Srilakulam - 532- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number T800304 on the bottle label. The product was manufactured in India with specific NDC and UPC codes.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.5 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product safe to use?
The recall indicates a contamination issue, so it is not safe to use as is. Contact Dr. Reddy's for proper handling.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1191-2018 (September 4, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1191-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.